Scholar Rock Holding Company (SRRK) got here out with a quarterly lack of $0.39 per share versus the Zacks Consensus Estimate of a lack of $0.57. This compares to lack of $0.43 per share a yr in the past. These figures are adjusted for non-recurring objects.
This quarterly report represents an earnings shock of 31.58%. 1 / 4 in the past, it was anticipated that this firm would put up a lack of $0.31 per share when it truly produced a lack of $0.55, delivering a shock of -77.42%.
Over the past 4 quarters, the corporate has surpassed consensus EPS estimates two occasions.
Scholar Rock Holding Company, which belongs to the Zacks Medical – Biomedical and Genetics business, posted revenues of $7.57 million for the quarter ended December 2019, surpassing the Zacks Consensus Estimate by 38.95%. This compares to zero revenues a yr in the past.
The sustainability of the inventory’s instant value motion based mostly on the recently-released numbers and…